Dose Finding Study in COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BEA 2180 BR

DRUG

tiotropium

Trial Locations (43)

Unknown

UAB Lung Health Center, Birmingham

Vapahcs 111P, Palo Alto

Boehringer Ingelheim Investigational Site, San Diego

GLAHS Sepulveda, Sepulveda

Rehabilitation Clinical Trial Center, Torrance

Boehringer Ingelheim Investigational Site, Wheat Ridge

Hospital for Special Care, New Britain

Bay Pines VA Medical Center, Bay Pines

Boehringer Ingelheim Investigational Site, Panama City

Boehringer Ingelheim Investigational Site, Pembroke Pines

Boehringer Ingelheim Investigational Site, Coeur d'Alene

LSUHSC - Shreveport, Shreveport

VAMC-Reno, Reno

North Shore Universtiy Hospital, New Hyde Park

SVMMC, Toledo

Boehringer Ingelheim Investigational Site, Medford

Hershey Medical Center, Hershey

Boehringer Ingelheim Investigational Site, Philadelphia

Frank Sciurba, Pittsburgh

Boehringer Ingelheim Investigational Site, Charleston

MUSC, Charleston

Boehringer Ingelheim Investigational Site, Spartanburg

Boehringer Ingelheim Investigational Site, Harker Heights

MEDVAMC, Houston

McGuire VA, Fredericksburg

Boehringer Ingelheim Investigational Site, Richmond

Boehringer Ingelheim Investigational Site, Tacoma

CHU du Sart Tilman (B35), Angleur

A.Z. VUB, Brussels

UZ Antwerpen, Edegem

AZ Jan Palfijn, Ghent

UZ Gent, Ghent

Virga Jesseziekenhuis, Hasselt

Clinique Reine Astrid, Malmedy

Heilig Hartziekenhuis, Menen

Sint-Elisabethziekenhuis, Turnhout

Ziekenhuisgroep Twente, Almelo

Amphia Ziekenhuis, Breda

Tjongerschans Ziekenhuis, Heerenveen

Atrium Medisch Centrum, Heerlen

Ziekenhuisgroep Twente, Hengelo

Academisch Ziekenhuis Nijmegen St. Radbout, Nijmegen

Gelre Ziekenhuizen, Zutphen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY